This dual-peptide research blend combines CJC-1295 (No DAC) and Ipamorelin for laboratory studies focused on growth hormone signaling, endocrine communication, and pathway timing. The pairing is commonly used to examine complementary receptor interactions within controlled GH-related research systems. CJC-1295 (No DAC) is typically studied for short-acting GHRH-pathway activity, while Ipamorelin is examined for selective ghrelin receptor-related signaling. Together, they provide a useful platform for investigating pulsatile signaling behavior, peptide synergy, and downstream metabolic or regenerative pathway effects. This product is supplied as a research blend for controlled laboratory handling by qualified professionals.
Compound: CJC-1295 (No DAC) + Ipamorelin Composition: CJC-1295 (No DAC) (5mg) + Ipamorelin (5mg) Total Content: 10mg blend per vial Form: Research peptide blend Storage: Store in a cool, dry environment. Protect from heat, moisture, and direct light
Growth hormone signaling studies GHRH and ghrelin pathway analysis Pulsatile endocrine signaling research Dual-peptide synergy investigations
This material is supplied exclusively for laboratory research use by qualified professionals. It is not intended for human or animal consumption, and must not be used in food, drugs, cosmetics, or diagnostic applications. All handling and use should comply with applicable laws, regulations, and institutional protocols.
